Acquisition of Baricol by FitForMe

Baricol_FFM-1 Acquisition of Baricol by FitForMe
Baricol2 Acquisition of Baricol by FitForMe

August 2022


Strategic acquisition


Consumer Health

Transaction Overview

Spayne Lindsay is delighted to announce that it has advised FitForMe on the acquisition of Baricol.


Baricol, founded in 2015 and based in Gothenburg, Sweden, offers bariatric surgery patients digital and holistic therapeutic solutions for a healthier life after surgery. Baricol provides personalised supplements for bariatric patients in Europe, the UK and the Middle East, and has recently developed the BariBuddy digital application that provides a solution for the long-term challenge of adherence to daily supplementation and healthy routines post-surgery.


FitForMe is a leading nutritional supplement brand founded in 2005 and based in Rotterdam, the Netherlands, that is active in more than 29 countries where it sells scientifically backed supplements to bariatric surgery patients. The acquisition of Baricol will allow FitForMe to deliver innovative solutions to support more patients globally.


Simon Hamer, Co-founder and CEO of FitForMe, commented:


“Baricol is the leading brand in the Scandinavian region and has developed BariBuddy, the innovative digital product for bariatric patients. This application supports patients in maintaining healthy routines after gastric bypass surgery. Our aim is to make these kind of innovations available on a large scale.”


“It has been a great pleasure working with the Spayne Lindsay team of Jonathon Martin, Hugh Jowett and Tommaso Turri. Their guidance and assistance has allowed us to close the deal in a way that was highly satisfactory for all parties at the table.”

Contact Spayne Lindsay for further information